Transaction in Own Shares

Summary by AI BETAClose X

Melrose Industries PLC has announced the purchase of 35,100 ordinary shares between June 15th and June 19th, 2026, through Merrill Lynch International. The volume-weighted average purchase price ranged from 469.27p to 482.34p per share. Following these transactions, the company now holds 65,206,026 shares in treasury, with 1,246,269,295 ordinary shares in issue.

Disclaimer*

Melrose Industries PLC
22 June 2026
 







22ⁿᵈ June 2026




Melrose Industries PLC

("Melrose" or the "Company")

Transaction in Own Shares

 






The Company announces today it has purchased the following number of its ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in the period from 15ᵗʰ June 2026 to 19ᵗʰ June 2026.







Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (pence)

Highest price per share (p)

15 June 2026

XLON

473.5475

6,300

467.8000

477.2000

16 June 2026

XLON

469.2681

6,300

466.0000

472.6000

17 June 2026

XLON

473.0854

6,400

469.5000

476.0000

18 June 2026

XLON

482.3406

6,200

479.8000

486.9000

19 June 2026

XLON

478.0958

6,100

473.5000

482.3000













The Company intends to hold the purchased shares in treasury.







Following the above transaction, the Company has 65,206,026 ordinary shares in treasury and has 1,246,269,295 ordinary shares in issue (excluding treasury shares).













Individual Transactions

 



In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the MLI on behalf of the Company as part of the buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/0989J_1-2026-6-19.pdf







For further information please contact:




Warren Fernandez                        Company Secretary



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings